市场调查报告书
商品编码
1499395
电外科市场:按产品类型、应用和最终用户划分 - 全球预测 2024-2030Electrosurgery Market by Product (Accessories, Argon Systems, Generators), Type (Bipolar Electrosurgical Devices, Monopolar Electrosurgery), Application, End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年电外科市场规模为70.9亿美元,预计2024年将达75.1亿美元,2030年将达到107.5亿美元,复合年增长率为6.13%。
电外科手术是一种常用高频电流切割组织或止血的医疗手术。此手术使用一种专用的设备,使电流穿过患者的组织,对其进行加热并达到所需的效果:切割、凝固、干燥和凝固组织。这种方法与传统手术不同,因为它出血较少,并且允许外科医生做出更精确的切口。电外科可用于各种医疗环境,包括皮肤和心臟手术以及肿瘤切除。由于癌症和心血管疾病等需要手术干预的疾病的增加,电外科技术的使用正在扩大。随着患者越来越多地寻求恢復时间更短、术后疼痛更少的手术,对支持微创手术的电外科手术的需求正在显着增加。此外,医疗保健基础设施支出的增加,特别是在新兴国家,正在扩大先进外科技术(包括电外科技术)的取得和采用。然而,与先进电外科设备相关的高成本可能会限制市场渗透,特别是在成本敏感的市场。此外,电烧烫伤和电击等併发症也会带来风险,这可能会阻碍某些地区的采用。此外,电外科设备的技术创新,例如排烟系统和氩离子凝固方法的开发,透过提高外科手术的安全性和有效性,为市场成长提供了良好的机会。
主要市场统计 | |
---|---|
基准年[2023] | 70.9亿美元 |
预测年份 [2024] | 75.1亿美元 |
预测年份 [2030] | 107.5亿美元 |
复合年增长率(%) | 6.13% |
区域洞察
美国市场因其先进的医疗基础设施、大量的研发投资以及创新手术技术的高采用率而成为电外科领域的领导者。该市场是由领先的医疗设备公司推动的,这些公司透过创新和新技术不断增强其产品。例如,美洲正在进行的技术创新着重于提高电外科器械的安全性和有效性、降低烧烫伤风险和改善病患治疗效果。欧盟国家受益于简化新医疗设备核准流程的法律规范。正在进行的倡议旨在改善手术结果并儘量减少侵入性手术,这推动了对电外科的需求。该领域的研究通常着重于提高心臟病学和神经病学等复杂手术中电外科设备的准确性。中东地区市场发展迅速,其中海湾国家由于医疗保健投资增加和医疗旅游增加而引领成长。儘管非洲在技术采用方面仍在发展,但随着医疗基础设施的改善和医疗设施的国际投资,它正在显示出潜力。在亚太地区,中国、日本和印度因其人口众多且医疗保健产业不断发展而成为电外科市场的重要国家。该地区持续不断的创新旨在开发具有成本效益的电外科设备,可广泛用于各种医疗手术。政府对医疗改革的支持和高科技医疗设备的采用是这一增长的主要推动力。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在电外科市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对电外科市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对当前电外科市场地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[191 Pages Report] The Electrosurgery Market size was estimated at USD 7.09 billion in 2023 and expected to reach USD 7.51 billion in 2024, at a CAGR 6.13% to reach USD 10.75 billion by 2030.
Electrosurgery is a medical procedure commonly used to cut tissue or to stop bleeding by using high-frequency electrical currents. The procedure involves using a specialized instrument that directs electrical currents through a patient's tissue, causing it to heat and achieve the desired effect, whether that is cutting, coagulating, desiccating, or fulgurating (shallow coagulation) tissue. This method is distinct from traditional surgery because there is less blood loss, and it allows surgeons to make more precise cuts. Electrosurgery can be used in a variety of medical circumstances, including surgeries involving skin and heart procedures and in the removal of tumors. The rising prevalence of disorders that require surgical intervention, such as cancers and cardiovascular diseases, expands the use of electrosurgery techniques. As patients seek procedures with shorter recovery times and less postoperative pain, the demand for electrosurgery, which supports minimally invasive techniques, significantly grows. Additionally, increased spending on healthcare infrastructure, particularly in emerging economies, expands the accessibility and adoption of advanced surgical technologies, including electrosurgery. However, high costs associated with advanced electrosurgical devices can limit market penetration, especially in cost-sensitive markets. Additionally, complications such as burns or shocks due to electric currents can pose risks, which may deter adoption in some regions. Furthermore, innovations in electrosurgery devices, such as the development of smoke evacuation systems and argon plasma coagulation, pose lucrative opportunities for market growth by improving the safety and effectiveness of surgical procedures.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 7.09 billion |
Estimated Year [2024] | USD 7.51 billion |
Forecast Year [2030] | USD 10.75 billion |
CAGR (%) | 6.13% |
Regional Insights
The American market is a leader in the electrosurgery field due to its advanced healthcare infrastructure, heavy investment in R&D, and high adoption of innovative surgical technologies. The extensive presence of major medical device companies, which continually enhance their products through innovation and new technologies, drives this market. For instance, ongoing innovations in the Americas have focused on enhancing the safety and effectiveness of electrosurgical instruments, reducing the risk of burns, and improving patient outcomes. Countries within the EU benefit from the collective regulatory framework that streamlines the approval processes for new medical devices. Ongoing initiatives aim to enhance surgical outcomes and minimize invasive procedures, which boosts the demand for electrosurgery. Research in this region often focuses on improving the precision of electrosurgical devices in complicated surgeries such as cardiology and neurology. The market in the Middle East region is rapidly evolving, with Gulf countries spearheading growth due to increasing healthcare investments and growing medical tourism. Africa, while still developing in terms of technology adoption, shows potential due to its enhanced healthcare infrastructure and international investment in medical facilities. In APAC, China, Japan, and India, with a large population and growing healthcare sector, make it a significant country in the electrosurgery market. Ongoing innovations in the region have aimed at creating cost-effective electrosurgical devices that can be widely used in various medical procedures. The government's push toward healthcare reform and the adoption of high-tech medical devices are significant drivers behind this growth.
Market Insights
The market dynamics represent an ever-changing landscape of the Electrosurgery Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Electrosurgery Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Electrosurgery Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Stratus Medical Expands RF Technology Patents in Europe
Stratus Medical, a Texas-based company in radiofrequency (RF) technologies for chronic pain management, announced the expansion of their European patent portfolio. These patents reinforce the protection of the company's NIMBUS Electrosurgical RF Multitined Expandable Electrode in several key European markets including the United Kingdom, Ireland, and Spain, and extend through the Unitary Patent system to include France, Germany, Italy, and other participating nations. [Published On: 2024-04-29]
Olympus Launches the ESG-410 Generator for Enhanced Bladder and Prostate Care
Olympus Corporation has introduced the ESG-410 Electrosurgical Generator, a pivotal advancement for the treatment of non-muscle-invasive bladder cancer (NMIBC) and benign prostatic hyperplasia (BPH). This latest model is engineered with superior features, including larger capacitors for improved plasma stability, resulting in more efficient energy usage and quicker tissue removal during procedures. The ESG-410 boasts a significant upgrade over its predecessor, the ESG-400, with enhancements such as faster ignition, a larger 8.4-inch LCD touchscreen, and both wireless and wired foot pedal options. [Published On: 2023-06-05]
Breakthrough Designation for Innoblative's Innovative SIRA RFA Device in Breast Cancer Surgery
Innoblative Designs, Inc. has achieved a prestigious milestone by receiving the Breakthrough Device Designation from the U.S. FDA for its SIRA RFA Electrosurgical Device. The SIRA device is specifically crafted for breast cancer patients undergoing breast-conserving surgery (BCS), targeting an enhanced surgical outcome by potentially reducing the rates of reoperation. This innovation aims to standardize treatment results by ensuring uniform energy application, potentially minimizing local cancer recurrence. [Published On: 2023-04-27]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Electrosurgery Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Electrosurgery Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Alcon Inc., AngioDynamics, Inc., Applied Medical Resources Corporation, Aspen Surgical Products, B. Braun SE, Baxter International Inc., Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Erbe Elektromedizin GmbH, Innoblative Designs, Inc., Integra LifeSciences, Intuitive Surgical, Inc., Johnson & Johnson Services, Inc., Karl Storz SE & Co. KG, KLS Martin SE & Co. KG, LED SpA, Medline Industries, LP, Medtronic PLC, Olympus Corporation, Smith & Nephew PLC, and Stryker Corporation.
Market Segmentation & Coverage